Google’s biggest AI reshuffle yet is being sold as an acceleration plan. Inside and outside the company, it is also being read as a warning that the old DeepMind balance between long-horizon science, product pressure and ethical restraint is breaking down.

On Wednesday, Alphabet said Demis Hassabis would give up day-to-day control of Google DeepMind, becoming its chair and Alphabet chief scientist while retaining leadership of Isomorphic Labs. DeepMind CTO Koray Kavukcuoglu will run the unit, reporting to Sundar Pichai. Hassabis said he wanted “the time and space to focus on the big picture.”¹

Pichai framed the move as a bid to turn Google’s formidable research assets into faster progress, saying the company must “accelerate all this work and stay focused on the AI frontier.”Sundar Pichai (sundarpichai)² The urgency is clear: reports point to delays for Gemini 3.5 Pro, while OpenAI and Anthropic have pressed ahead with powerful new models, particularly in lucrative coding tools.³

The same day brought a more emotionally charged departure. Jeff Dean, Google’s 30th employee and a 27-year veteran, is leaving with Sanjay Ghemawat, Quoc Le and Oriol Vinyals to launch Discovery Loop, a public-benefit startup aimed at automating scientific and engineering experiments. Pichai hailed Dean’s “incredible 27-year run” and said Google would support the venture.Sundar Pichai (sundarpichai)⁴

For many employees, that reassurance did little to soften the blow. Internal posts memorialized Dean with the familiar mythology of “Jeff Dean Facts”; one meme declared, “Google is not losing Jeff Dean. Google is finally open-sourcing him for humanity.”⁵ Others saw the exit as a deeper loss of institutional weight and dissent.

That criticism intersects with Google’s April Pentagon agreement, which permits military use of its AI for any lawful purpose. Former and current staff have linked the deal to departures and argued that Dean and Hassabis had previously opposed mass surveillance and autonomous lethal weapons. One current employee called Dean’s exit evidence that “the vestiges of Google’s idealism” were dying out.⁶

Google insists the changes are not a retreat: it still has elite researchers, custom chips, cloud infrastructure and cash. Yet with Hassabis moved toward the future of AGI and Dean headed out the door, the immediate question is whether a company built on patient research can now move fast without shedding what made it distinctive.